New Therapy Protects Chimps from Hep C Virus | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Hepatitis C Biopump Trials Get Green Light

Back to News Homepage
Next

Are There Shades of Grey in Hepatitis C Treatment Success?

New Therapy Protects Chimps from Hep C Virus

The Editors at Hepatitis Central
September 5, 2012

Print this page

Based on a chimpanzee study, scientists have found that a high dose of human monoclonal antibody targeting Hepatitis C delivered protection against this potent liver virus.

Antibody prevents hepatitis C in animal model

Posted On: August 30, 2012 – 9:30pm

A monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) and tested in an animal model at the Texas Biomedical Research Institute, prevents infection by the hepatitis C virus (HCV).

Researchers found that the human monoclonal antibody targeting the virus protected chimpanzees from HCV infection in a dose-dependent manner in a study conducted at Texas Biomed’s Southwest National Primate Research Center. Chimpanzees are the only species other than humans that can be infected by HCV and therefore the results from this study were critical in the development of the monoclonal antibody.

Continue reading this entire article:
http://www.sciencecodex.com/antibody_prevents_hepatitis_c_in_animal_model-97637

2 Comments
Share
Share
Previous

Hepatitis C Biopump Trials Get Green Light

Back to News Homepage
Next

Are There Shades of Grey in Hepatitis C Treatment Success?

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.